TerminatedNCT02827513
A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects
Medication studyAges 18–45AustraliaADHD
Understand this study
Who could participate?
Listed age limits: 18 years to 45 years.
- Listed locations
- MelbourneSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateDecember 2015
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 16
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- Australia
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT02827513
- Official title
Show the full official title
A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) (Formerly Called EB-1020) in Young Healthy Subjects
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Melbourne
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Otsuka Pharmaceutical Development & Commercialization, Inc., a pharmaceutical company.
Does this study involve medication?
Yes. The study involves medication, including CTN SR1, CTN XR1, CTN XR2 and CTN XR3.
Who can participate?
Listed age limits: 18 years to 45 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
Improving outcomes in mental health for children and families: A study of Enhanced Stepping Stones Triple P
The AutoMHAN Project: an exploratory study investigating circadian and Autonomic Nervous System characteristics such as heart rate, sleep and activity in Mental Health and Neurodevelopmental Disorders in children and adolescents.
